After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Budget calculator numbers can be opaque. Learn what they mean and how to translate them into concrete next steps.
17,878 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Cramer confronted his past mega-cap bets on Mad Money, pivoting to a bullish view on Corning as supplier demand remai...
As market dynamics shift in 2026, investors weigh broad market exposure against a tech-heavy Nasdaq-100 tilt. This re...
In 2026, investors face a choice between a pure digital disruptor in LatAm and a large US consumer lender with a heav...
A zero-premium Medicare Advantage plan can suddenly require steep out-of-network costs when a preferred surgeon isn’t...
Meta Platforms trades around $630 amid 2026 market volatility, but bulls say rising ad pricing and early AI monetizat...
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
Sandisk surged more than 3,000% in the past year, turning heads and raising questions about valuation and future move...
A newly launched active ETF has delivered stronger net returns than the S&P 500 after costs over the latest 12-month ...
A surge in AI workloads is testing chipmakers worldwide. This piece explains why tsmc can't make chips fast enough, w...
OpenAI CEO Sam Altman says AI could someday run a major company better than its human leadership, a warning that coul...